reSee.it - Related Video Feed

Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1,500 a month, and most have taken money from Novo Nordisk, the drug's manufacturer. There is a push to recommend Ozempic for Americans as young as six for obesity, a condition claimed to be preventable. It is claimed that if 74% of Americans took Ozempic, the cost would be $3 trillion a year. Ozempic has made Novo Nordisk the biggest company in Europe, yet the Danish government recommends diet and exercise instead. It is claimed that for half the price of Ozempic, every American could receive regeneratively raised organic food and gym memberships. It is claimed that members of Congress are doing the bidding of Novo Nordisk instead of standing up for American farmers and children because Novo Nordisk is one of the largest funders of medical research.

We cannot approve nominees who pose a risk to public health, particularly regarding Robert F. Kennedy, Jr. This is a pressing concern for the upcoming Congress. We are facing a significant crisis: one in five children is obese, and millions are battling diabetes. The American Diabetes Association reports that we spend over $400 billion annually on diabetes and related illnesses. The urgency of addressing this issue needs to be more clearly communicated, as it affects the health of our population.

This is a systemic issue that needs addressing. I've expressed concern about a future where the FDA is remembered for allowing society to gain weight annually, only to respond with an expensive drug costing $20,000 a year. That would leave a troubling legacy. I hope we can find a better solution.

Over 100 members of Congress are backing a bill to fund Ozempic through Medicare at $1,500 monthly, many having received funds from Novo Nordisk, its European manufacturer. Once Medicare approves it, Medicaid follows. There's a push to prescribe Ozempic to kids as young as six for obesity, a largely preventable condition. With 74% of Americans obese, covering everyone's Ozempic would cost $3 trillion annually. Ozempic has made Novo Nordisk Europe's largest company, yet Denmark recommends diet and exercise instead. The company's value relies heavily on projected Ozempic sales in the US. For half the cost, we could provide organic food and gym memberships for every obese American. Why are politicians siding with a Danish company over American farmers and kids? Because Novo Nordisk heavily funds medical research, influencing media, politicians, and medical schools.

Over 100 members of Congress support a bill to fund Ozempic through Medicare at $1,500 a month, despite many having received funding from its manufacturer, Novo Nordisk. This drug, aimed at treating obesity—a largely preventable condition—could cost the U.S. $3 trillion annually if prescribed widely, as 74% of Americans are obese. While Novo Nordisk thrives, the Danish government promotes diet and exercise instead. For half the cost of Ozempic, we could provide organic food and gym memberships for every obese American. The influence of Novo Nordisk extends to medical research funding, leading to complicity from media, politicians, and medical schools.

Speaker 0 argues that history will view this presidency as probably the most reckless and corrupt in the history of the United States, and expresses fear that without change the country and the world risk major harm, including the possibility of World War III. They say, regardless of views on global leadership, that being on top “what good is it … if you've created an absolute hellscape?” They emphasize the need for the course to change and suggest the future of the United States as a cohesive country and the world is currently in question because of the administration’s behavior. Speaker 1 agrees that America used to hold the moral high ground—defending human rights, free speech, and free trade—but asserts that none of those things are true any longer. They claim America is “the terror regime of the world,” describing it as pillaging, stealing, bombing, assassinating, running color revolutions, lying, and doing everything possible to destroy others to keep America as the last nation standing on its pile of soon to be worthless debt. They state this is not a moral position from which to lead any civilization. Speaker 0 contends that America has the tools to be all those values, citing a great constitutional republican system, the federation of states, resources, and human capital. They note a problem, however: a “giant pile of worthless fiat paper,” with the bill coming due and the tantrums of an empire, referencing warnings by people like Gerald Celente and Alex Jones about a fiat bubble rupture. They say the question is where the country wants to be in the world, criticizing a lack of imagination among the “great and the good in America” about a compelling future. Speaker 1 adds a new issue: 31 million Americans are injecting themselves with GLP-1 drugs, which they say cause a 100% increase in risk of psychiatric disorders and suicidal ideation, especially among women, with the most use among 50–65-year-olds. They claim Trump is working to make these drugs more affordable so that more people can take them, potentially leading to half of US adults using a drug based on venom peptides of the Gila monster, a paralyzing agent, risking madness. They compare this to lead poisoning and reference Ozempic as one of these drugs. Speaker 0 asks, “What’s it called? Ozempic? Is that a GOP one?” Speaker 1 confirms “Ozempic,” and notes that the drugs are used for vanity to look healthy, not because people are actually healthy. They reiterate the core issue: what goes into bodies and the environment in which people live, stressing that there is an opportunity today to correct and improve the situation, and that many are taking that opportunity.

Ozempic breaks people's bones. Pharmaceutical companies selling weight loss pills have side effects that include breaking people's bones. Instead of cleaning up their diet, eating organic, working out, getting rid of Wi Fi, and spending time in nature, people are going to pharmaceutical companies expecting results. When your bones break in half, it doesn't matter if you lose weight. Taking care of yourself and being healthy takes work. If you're concerned about weight loss, you should be concerned about what's in your house, what you're eating, the chemicals you're spraying all over your body, and the lotions you're putting all over your head. If you can't lose weight, it's probably your diet, and an all-organic diet can heal everything. Pharmaceutical companies poison people to gain weight, then sell them something to make them lose weight, which causes their bones to break, creating patients for life.

Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1,500 monthly, with most having received money from Novo Nordisk, its manufacturer. Approval for Medicare would extend to Medicaid, with potential recommendations for Americans as young as six for obesity, a condition claimed to be preventable and recently rare. With 74% of Americans obese, the total cost of Ozempic prescriptions could reach $3 trillion annually. Ozempic has made Novo Nordisk the biggest company in Europe, yet the Danish government recommends diet and exercise instead. The company's value relies on projected Ozempic sales in America. For half the cost of Ozempic, every American could receive regeneratively raised organic food and obese Americans could receive gym memberships. The speaker questions why Congress is supporting Novo Nordisk over American farmers and children, suggesting Novo Nordisk's funding of medical research influences media, politicians, and medical schools.

Novo Nordisk, the pharmaceutical company behind the weight loss drug Ozempic, is debunking conspiracy theories about profiting off people's health issues. They are lobbying the government to support the Treat and Reduce Obesity Act of 2023, which allows coverage for obesity treatment under Medicare. The company's stock has seen significant growth, and they have spent millions on lobbying and stock buybacks. While some board members have connections to other companies, Novo Nordisk aims to improve people's health. Critics argue that the drug has side effects and is expensive, but an article by Yoni Friedhoff, who received grants from Novo Nordisk, refutes these claims. Trusting the science and pharmaceutical companies is important for better health.

Medicine is important for specific treatments, but primary care should emphasize lifestyle changes before prescribing medication. It's easier to prescribe drugs like omeprazole than to advise weight loss and dietary changes, but these medications can cause problems like osteoporosis or C. Diff. Overweight patients often need higher doses of medication, but weight loss should be the first step. Doctors may over-prescribe medication to allow patients to continue unhealthy habits, like eating steak. Instead, people should balance indulgences with healthier choices. Doctors may favor drugs like Ozempic because they offer a quick solution when lifestyle changes seem improbable. Insurance may cover weight loss medication but offer limited support for nutritionists. There should be incentives in the workplace to encourage exercise.

Over 100 members of Congress support a bill to fund Ozempic through Medicare at $1,500 a month, despite many having received funding from its manufacturer, Novo Nordisk. Once approved for Medicare, the drug will likely extend to Medicaid, with recommendations for use in children as young as 6 for obesity, a largely preventable condition. With 74% of Americans classified as obese, the potential annual cost for Ozempic prescriptions could reach $3 trillion. While Novo Nordisk thrives on these projections, the Danish government advocates for dietary changes and exercise instead. For the cost of Ozempic, we could provide organic food and gym memberships for every obese American. The influence of Novo Nordisk in medical research funding raises concerns about Congress prioritizing corporate interests over American health and agriculture.

Politicians have long promised to eliminate the discrepancy between drug prices in the U.S. and Europe. This was a key issue for Bernie Sanders, but previous leaders haven't acted on it. Politicians make these promises knowing they likely won't have to fulfill them. The reason is that Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every congressman, senator, and Supreme Court member.

Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1500 a month, and most have taken money from Novo Nordisk, the drug's manufacturer. Once approved for Medicare, it goes to Medicaid, and there's a push to recommend Ozempic for Americans as young as 6 for obesity, a condition claimed to be preventable and recently rare. With 74% of Americans obese, the cost of Ozempic prescriptions for all of them would be $3 trillion a year. Novo Nordisk's value is based on projected Ozempic sales to Americans, yet the Danish government recommends diet and exercise instead. For half the price of Ozempic, every American could receive regeneratively raised organic food and gym memberships. Congress is allegedly doing the bidding of Novo Nordisk instead of supporting American farmers and children because Novo Nordisk heavily funds medical research, the media, politicians, and medical schools.

Ozempic has rapidly become a cultural phenomenon, with one in eight US adults having tried GLP-1 drugs. The company producing Ozempic is now valued higher than Coca-Cola and McDonald's combined. Online discussions mention side effects like Ozempic face, hair loss, and severe stomach problems, alongside reports suggesting potential benefits for fertility, Alzheimer's, and even shopping addiction. The speaker questions the complete truth about GLP-1 drugs and weight loss, and has spent months researching and attempting to obtain GLP-1 medication.

Politicians have long promised to address the discrepancy between drug prices in the U.S. and Europe. This issue was central to Bernie Sanders' presidential campaigns. However, these promises were never fulfilled because Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every member of Congress, the Senate, and the Supreme Court.

Ozempic causes appetite suppression, leading to weight loss, but also nausea and vomiting, causing some to stop usage. While effective and offering metabolic benefits from weight loss, it's very expensive, costing $1,300-$1,700 monthly. Weight returns upon cessation without lifestyle changes; it doesn't address behavior or habits. A significant downside is muscle loss, with 50% of weight lost being muscle, which is crucial for metabolism and overall health. Counteracting this requires increased protein intake and weight training. Metabolism may be slower post-treatment due to muscle loss. Long-term side effects are emerging, including a 450% increase in bowel obstruction and a 900% increase in pancreatitis. The drug addresses a symptom, not the cause, which is a toxic environment, lifestyle, and food system. Addressing obesity requires policy changes, agricultural and food system reform, and widespread education, which faces resistance from the large food industry.

Big food, big pharma, big chemicals get super wealthy. Right? What is the product of health care? It's a healthy body. If we take The US population and compare it to the world, we're at the very bottom when it comes to health, yet we spend the most for health care. Over $4,100,000,000,000 every single year.

The average 65-year-old in the US takes about seven drugs. 95% of people on the USDA nutrition guidelines had conflicts of interest with food companies, influencing school lunches, where the USDA serves 3 billion meals yearly. Kraft Heinz is brokering deals to put Lunchables in schools, a top growth area. Novo Nordisk, the Ozempic manufacturer, is now Europe's most valuable company, with almost all revenue from the US due to a broken system. 30% of Americans with insurance coverage stop using Ozempic within three months, despite it being touted as a lifetime drug. Lawsuits are emerging regarding gastrointestinal issues and stomach paralysis, which may persist after discontinuing the drug. The EU is probing suicidal ideation linked to Ozempic. The American Academy of Pediatrics recommends Ozempic as a first-line defense for teens based on a 68-week study. Pharma is the largest TV news ad spender, and Novo Nordisk is a major funder of obesity research, medical groups, and civil rights groups, including paying the NAACP, who claims that not supporting Ozempic is racist. Analyst reports assume increased obesity rates, and loans for obesity treatment centers project growth in obesity. Weight Watchers, now an Ozempic prescriber, shifted from personal accountability due to Ozempic's superior business model.

Obesity is America's deadliest epidemic, contributing to half a million deaths yearly. Seventy-four percent of Americans are overweight. The problem isn't personal failure; it's a broken system. The $160 billion weight-loss industry profits from our struggles, prioritizing profits over patients. Existing medications can be effective, but are often unaffordable. Hims & Hers offers a solution: affordable, doctor-approved weight-loss medication, formulated in the USA. We provide personalized treatment plans tailored to individual needs and lifestyles. We believe everyone deserves to feel good in their body. Join us in building a healthier America.

Ozempic, a diabetes drug that aids weight loss, is gaining popularity despite concerns. Cali Means highlights three major issues: first, obesity is a symptom of deeper metabolic dysfunction, not a deficiency treatable by medication. Second, the drug has significant side effects, including gastrointestinal issues and potential mental health risks, with many users discontinuing it within months. Third, systemic corruption in healthcare, where pharmaceutical companies influence medical guidelines and funding, exacerbates the problem. Instead of addressing root causes like diet and lifestyle, the focus remains on lifelong drug dependency. Means advocates for a shift towards preventive measures, emphasizing better nutrition and exercise as essential for improving public health. He believes that reforming healthcare practices and policies can reverse the current metabolic health crisis.

The U.S. faces a severe chronic disease crisis, costing $4.3 trillion annually, which is five times the military budget. Medical expenses for chronic diseases have skyrocketed from zero during previous administrations to 95% of healthcare spending today. This situation is exacerbated by processed foods, chemicals, and a profit-driven healthcare system that benefits from keeping people sick. Pharmaceutical companies profit from lifelong patients, with drugs like Ozempic costing $1,500 weekly. A proposed bill could lead to $3 trillion in costs for treating obesity. Instead, for a fraction of that amount, providing every American with three organic meals daily could eliminate diabetes, a condition treatable with proper nutrition and exercise.